United States Low Molecular Weight Heparin Market Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Low Molecular Weight Heparin

Revenue, means the sales value of Low Molecular Weight Heparin

This report studies sales (consumption) of Low Molecular Weight Heparin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Low Molecular Weight Heparin in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Low Molecular Weight Heparin Market Report 2016

Table of Contents
United States Low Molecular Weight Heparin Market Report 2016
1 Low Molecular Weight Heparin Overview
1.1 Product Overview and Scope of Low Molecular Weight Heparin
1.2 Classification of Low Molecular Weight Heparin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Low Molecular Weight Heparin
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Low Molecular Weight Heparin (2011-2021)
1.4.1 United States Low Molecular Weight Heparin Sales and Growth Rate (2011-2021)
1.4.2 United States Low Molecular Weight Heparin Revenue and Growth Rate (2011-2021)
2 United States Low Molecular Weight Heparin Competition by Manufacturers
2.1 United States Low Molecular Weight Heparin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Low Molecular Weight Heparin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Low Molecular Weight Heparin Average Price by Manufactures (2015 and 2016)
2.4 Low Molecular Weight Heparin Market Competitive Situation and Trends
2.4.1 Low Molecular Weight Heparin Market Concentration Rate
2.4.2 Low Molecular Weight Heparin Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Low Molecular Weight Heparin Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Low Molecular Weight Heparin Sales and Market Share by Type (2011-2016)
3.2 United States Low Molecular Weight Heparin Revenue and Market Share by Type (2011-2016)
3.3 United States Low Molecular Weight Heparin Price by Type (2011-2016)
3.4 United States Low Molecular Weight Heparin Sales Growth Rate by Type (2011-2016)
4 United States Low Molecular Weight Heparin Sales (Volume) by Application (2011-2016)
4.1 United States Low Molecular Weight Heparin Sales and Market Share by Application (2011-2016)
4.2 United States Low Molecular Weight Heparin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Low Molecular Weight Heparin Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Low Molecular Weight Heparin Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Low Molecular Weight Heparin Manufacturing Cost Analysis
6.1 Low Molecular Weight Heparin Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Low Molecular Weight Heparin
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Low Molecular Weight Heparin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Low Molecular Weight Heparin Market Forecast (2016-2021)
10.1 United States Low Molecular Weight Heparin Sales, Revenue Forecast (2016-2021)
10.2 United States Low Molecular Weight Heparin Sales Forecast by Type (2016-2021)
10.3 United States Low Molecular Weight Heparin Sales Forecast by Application (2016-2021)
10.4 Low Molecular Weight Heparin Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Low Molecular Weight Heparin
Table Classification of Low Molecular Weight Heparin
Figure United States Sales Market Share of Low Molecular Weight Heparin by Type in 2015
Table Application of Low Molecular Weight Heparin
Figure United States Sales Market Share of Low Molecular Weight Heparin by Application in 2015
Figure United States Low Molecular Weight Heparin Sales and Growth Rate (2011-2021)
Figure United States Low Molecular Weight Heparin Revenue and Growth Rate (2011-2021)
Table United States Low Molecular Weight Heparin Sales of Key Manufacturers (2015 and 2016)
Table United States Low Molecular Weight Heparin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Low Molecular Weight Heparin Sales Share by Manufacturers
Figure 2016 Low Molecular Weight Heparin Sales Share by Manufacturers
Table United States Low Molecular Weight Heparin Revenue by Manufacturers (2015 and 2016)
Table United States Low Molecular Weight Heparin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Low Molecular Weight Heparin Revenue Share by Manufacturers
Table 2016 United States Low Molecular Weight Heparin Revenue Share by Manufacturers
Table United States Market Low Molecular Weight Heparin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Low Molecular Weight Heparin Average Price of Key Manufacturers in 2015
Figure Low Molecular Weight Heparin Market Share of Top 3 Manufacturers
Figure Low Molecular Weight Heparin Market Share of Top 5 Manufacturers
Table United States Low Molecular Weight Heparin Sales by Type (2011-2016)
Table United States Low Molecular Weight Heparin Sales Share by Type (2011-2016)
Figure United States Low Molecular Weight Heparin Sales Market Share by Type in 2015
Table United States Low Molecular Weight Heparin Revenue and Market Share by Type (2011-2016)
Table United States Low Molecular Weight Heparin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Low Molecular Weight Heparin by Type (2011-2016)
Table United States Low Molecular Weight Heparin Price by Type (2011-2016)
Figure United States Low Molecular Weight Heparin Sales Growth Rate by Type (2011-2016)
Table United States Low Molecular Weight Heparin Sales by Application (2011-2016)
Table United States Low Molecular Weight Heparin Sales Market Share by Application (2011-2016)
Figure United States Low Molecular Weight Heparin Sales Market Share by Application in 2015
Table United States Low Molecular Weight Heparin Sales Growth Rate by Application (2011-2016)
Figure United States Low Molecular Weight Heparin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Low Molecular Weight Heparin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Low Molecular Weight Heparin
Figure Manufacturing Process Analysis of Low Molecular Weight Heparin
Figure Low Molecular Weight Heparin Industrial Chain Analysis
Table Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2015
Table Major Buyers of Low Molecular Weight Heparin
Table Distributors/Traders List
Figure United States Low Molecular Weight Heparin Production and Growth Rate Forecast (2016-2021)
Figure United States Low Molecular Weight Heparin Revenue and Growth Rate Forecast (2016-2021)
Table United States Low Molecular Weight Heparin Production Forecast by Type (2016-2021)
Table United States Low Molecular Weight Heparin Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting&hellip
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and&hellip
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries,&hellip
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the&hellip
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The&hellip
  • Global and United States Bacillus Subtilis Depth Research Report 2017-2022
    Published: 26-Jul-2017        Price: US 3190 Onwards        Pages: 108
    This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Depth Research Report, it covers all details inside analysis and opinion in Bacillus Subtilis industry. This report focus United States market, it covers details players regions product type and other details as following: Major Companies - Bayer (Germany) - BASF (Germany) - Tonglu Huifeng (C......
  • Global Medical Tape and Bandage Market Research Report 2017
    Published: 25-Jul-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global Medical Tape and Bandage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Medical Tape and Bandage in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global Baby Warm Scales Market Research Report 2017
    Published: 25-Jul-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Baby Warm Scales market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Baby Warm Scales in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Arthroscopy Shaver Market Research Report 2017
    Published: 25-Jul-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Arthroscopy Shaver market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Arthroscopy Shaver in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • Global Lixisenatide Market Professional Survey Report 2017
    Published: 25-Jul-2017        Price: US 3500 Onwards        Pages: 101
    This report studies Lixisenatide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Sanofi-Aventis - Zealand - ... By types, the market can be spli......
  • Global Diabetic Therapeutic Drugs Market Size, Status and Forecast 2022
    Published: 25-Jul-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global Diabetic Therapeutic Drugs market, analyzes and researches the Diabetic Therapeutic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - Novartis - AstraZeneca - Eli Lilly - Merck - Novo Nordisk - Sanofi - F. Hoffmann-La Roche - Takeda Pharmaceuticals - Sun Pharma - Perle......
  • EMEA (Europe, Middle East and Africa) Plaque Disclosing Market Report 2017
    Published: 25-Jul-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the EMEA Plaque Disclosing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Plaque Disclosing for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; ......
  • EMEA (Europe, Middle East and Africa) Neurological Biomarkers Market Report 2017
    Published: 25-Jul-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the EMEA Neurological Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Neurological Biomarkers for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Be......
  • EMEA (Europe, Middle East and Africa) Intravenous Product Packaging Market Report 2017
    Published: 25-Jul-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the EMEA Intravenous Product Packaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Intravenous Product Packaging for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, I......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs